Pubblicazioni

Effect of Comorbidities on Response Outcomes with First-Line Tyrosine Kinase Inhibitors (TKIs), Dasatinib Versus Imatinib, in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Exploratory Post Hoc Analysis of DASISION

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Breccia, Massimo; Mauro, Michael; Jabbour, Elias; Saglio, Giuseppe; Jimenez-Velasco, Antonio; le Coutre, Philipp; Degutis, Irene; Khan, Wasiulla; Sy, Oumar; Swanink, Rene; Cortes, Jorge E.